Kon, Edo
Ad-El, Nitay http://orcid.org/0000-0002-1936-8628
Hazan-Halevy, Inbal
Stotsky-Oterin, Lior
Peer, Dan http://orcid.org/0000-0001-8238-0673
Article History
Accepted: 25 July 2023
First Online: 16 August 2023
Competing interests
: D.P. receives licensing fees (to patents on which he was an inventor), has invested, has consulted, has been on the scientific advisory boards or boards of directors, given paid lectures or conducted research at Tel Aviv University sponsored by ART Biosciences, BioNTech, Earli, Kernal Biologics, Merck, NeoVac, Newphase, Roche, SirTLabs Corporation and Teva Pharmaceuticals. All other authors declare no competing financial interests.